Mehrdokht Sadrkhanloo

515 citations
10 papers · 381 indexed · h-index 8
Topics
Cancer-related molecular mechanisms research (6 papers)Circular RNAs in diseases (5 papers)MicroRNA in disease regulation (5 papers)
Partner nations
IranTürkiyeAustralia

In The Last Decade

Mehrdokht Sadrkhanloo

10 papers receiving 381 citations

Peers

Mehrdokht Sadrkhanloo
Comparison fields: 5 of 72
  • Molecular Biology 245
  • Cancer Research 180
  • Oncology 88
  • Pulmonary and Respiratory Medicine 57
  • Immunology 46
Replace Xiaofeng Zou with:
Xiaofeng Zou China
Yuening Sun China
Taolang Li China
Zhenkun Xia China
Zhenqing Sun China
Zhe Guo China
Ibone Labiano Spain
Zirui Zhao China
Mehrdokht Sadrkhanloo relative to Xiaofeng Zou China Xiaofeng Zou's profile →
Citations per field
00.5×1.6×
Xiaofeng Zou · 1×
Citations per year

Countries citing papers authored by Mehrdokht Sadrkhanloo

Since Specialization
Citations

This map shows the geographic impact of Mehrdokht Sadrkhanloo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehrdokht Sadrkhanloo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehrdokht Sadrkhanloo more than expected).

Fields of papers citing papers by Mehrdokht Sadrkhanloo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mehrdokht Sadrkhanloo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehrdokht Sadrkhanloo. The network helps show where Mehrdokht Sadrkhanloo may publish in the future.

Co-authorship network of co-authors of Mehrdokht Sadrkhanloo

This figure shows the co-authorship network connecting the top 25 collaborators of Mehrdokht Sadrkhanloo. A scholar is included among the top collaborators of Mehrdokht Sadrkhanloo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mehrdokht Sadrkhanloo. Mehrdokht Sadrkhanloo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 35
2 13
3 3
4 114
5 24
6 48
7 11
8 84
9 5
10 44

About Mehrdokht Sadrkhanloo

Mehrdokht Sadrkhanloo is a scholar working on Cancer Research, Physiology and Pathology and Forensic Medicine, having authored 10 papers that have together received 381 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), Circular RNAs in diseases (5 papers) and MicroRNA in disease regulation (5 papers). The work is most often cited by research in Cancer Research (180 citations), Molecular Biology (245 citations) and Oncology (88 citations). Mehrdokht Sadrkhanloo has collaborated with scholars based in Iran, Türkiye and Australia. Frequent co-authors include Maliheh Entezari, Mehrdad Hashemi, Afshin Taheriazam, Mohsen Rashidi, Saeed Samarghandian, Kiavash Hushmandi, Ali Zarrabi, Sima Orouei, Sepideh Mirzaei and Shokooh Salimimoghadam. Their work appears in journals such as Life Sciences, European Journal of Pharmacology and Pharmacological Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026